Low intensity exercise training in patients with amyotrophic lateral sclerosis – factors influencing eligibility and compliance to the clinical trial

References

• Abshire M, Dinglas VD, Cajita MIA, et al. Participant retention practices in longitudinal clinical research studies with high retention rates. BMC Med Res Methodol. 2017;17(1):30. DOI:10.1186/s12874-017-0310-z
   PubMedGoogle Scholar
• Feldman EL, Goutman SA, Petri S, et al. Amyotrophic lateral sclerosis. Lancet. 2022 Oct 15;400(10360):1363–1380. Epub 2022 Sep 15. PMID: 36116464. DOI:10.1016/S0140-6736(22)01272-7
   PubMed Web of Science ®Google Scholar
• Al-Nasser MN, Mellor IR, Carter WG. Is L-Glutamate toxic to neurons and thereby contributes to neuronal loss and neurodegeneration? A systematic review. Brain Sci. 2022 Apr 29;12(5):577. PMID: 35624964; PMCID: PMC9139234. DOI:10.3390/brainsci12050577.
   PubMed Web of Science ®Google Scholar
• Johnson SA, Fang T, De Marchi F, et al. Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents. Drugs. 2022;82(13):1367–1388. DOI:10.1007/s40265-022-01769-1
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Dinkova-Kostova AT, et al. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. 2010;13(11):1763–1811. DOI:10.1089/ars.2009.3074
   PubMed Web of Science ®Google Scholar
• Francesca S, De Marchi F, Mazzini L, et al. CELL THERAPY in ALS: an update on preclinical and clinical studies. Brain Res Bull. 2023 Jan 20;S0361-9230(23):00012–6. Epub ahead of print. PMID: 36690163. DOI:10.1016/j.brainresbull.2023.01.008
   Google Scholar
• Lejman J, Panuciak K, Nowicka E, et al. Gene therapy in ALS and SMA: advances, challenges and perspectives. Int J Mol Sci. 2023 Jan 6;24(2):1130. PMID: 36674643; PMCID: PMC9860634. DOI:10.3390/ijms24021130
   PubMed Web of Science ®Google Scholar
• Jiang J, Wang Y, Deng M. New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022. Front Pharmacol. 2022 Nov 28;13:1054006. PMID: 36518658; PMCID: PMC9742490. DOI:10.3389/fphar.2022.1054006.
   PubMed Web of Science ®Google Scholar
• Camu W, De La Cruz E, Esselin F. Therapeutic tools for familial ALS. Rev Neurol (Paris). 2022 Dec 8;S0035-3787(22):00818–9. Epub ahead of print. PMID: 36503675. DOI:10.1016/j.neurol.2022.10.001.
   Google Scholar
• Atassi N, Yerramilli-Rao P, Szymonifka J, et al. Analysis of start-up, retention, and adherence in ALS clinical trials. Neurology. 2013;81(15):1350–1355. DOI:10.1212/WNL.0b013e3182a823e0
   PubMed Web of Science ®Google Scholar
• Chiò A, Canosa S, Gallo S, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology. 2011 Oct;77(15):1432–1437. DOI:10.1212/WNL.0b013e318232ab9b.
   PubMed Web of Science ®Google Scholar
• Drory VE, Goltsman E, Reznik JG, et al. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001; Oct 15;191(1–2):133–137. DOI:10.1016/s0022-510x(01)00610-4.
   PubMed Web of Science ®Google Scholar
• Bello-Haas Vp D, Florence JM, Kloos AD, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007;68(23):2003–2007.
   PubMed Web of Science ®Google Scholar
• Wen D, Fan Y, Hsu SH, et al. Combining brain-computer interface and virtual reality for rehabilitation in neurological diseases: a narrative review. Ann Phys Rehabil Med. 2021 Jan;64(1):101404. DOI:10.1016/j.rehab.2020.03.015.
   PubMed Web of Science ®Google Scholar
• Mehrholz J, Harvey LA, Thomas S, et al. Is body-weight-supported treadmill training or robotic-assisted gait training superior to overground gait training and other forms of physiotherapy in people with spinal cord injury? A systematic review. Spinal Cord. 2017 Aug;55(8):722–729.
   PubMed Web of Science ®Google Scholar
• Toigo M, Flück M, Riener R, et al. Robot-assisted assessment of muscle strength. J Neuroeng Rehabil. 2017; Oct 11;14(1):103. DOI:10.1186/s12984-017-0314-2.
   PubMedGoogle Scholar
• Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293–299. DOI:10.1080/146608200300079536.
   PubMed Web of Science ®Google Scholar
• Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exercise. 1982;14(5):377–381.
   PubMed Web of Science ®Google Scholar
• Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Bil Fenn. 1957;35:307–315.
   PubMedGoogle Scholar
• Rehabilitation at the National Health Fund [Internet]. Warsaw. [cited 2022 Sep 7]; Available from: https://swiatprzychodni.pl/specjalnosci/rehabilitacja/
   Google Scholar
• Pereira MF, Buchanan T, Höglinger GU, et al. Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study. BMJ Neurol Open. 2022; Jan 21;4(1):e000214. DOI:10.1136/bmjno-2021-000214.
   PubMedGoogle Scholar
• UKMND-LiCALS Study Group. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013 Apr;12(4):339–345. DOI:10.1016/S1474-4422(13)70037-1
   PubMed Web of Science ®Google Scholar
• Wood AM, White IR, Thompson SG. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials. 2004;1(4):368–376.
   PubMedGoogle Scholar
• Sulzer P, Gräber S, Schaeffer E, et al. Cognitive impairment and sedentary behavior predict health-related attrition in a prospective longitudinal Parkinson’s disease study. Parkinsonism Relat Disord. 2021 Jan;82:37–43. DOI:10.1016/j.parkreldis.2020.11.015.
   PubMed Web of Science ®Google Scholar
• Medical rehabilitation/What every patient should know [Internet]. Warsaw. [cited 2022 Sep 7]; Available from: http://www.nfz-warszawa.pl/dla-pacjenta/co-kazdy-pacjent-wiedziec-powinien/ehabilitacjalecznicza/
   Google Scholar
• Schönfelder E, Osmanovic A, Müschen LH, et al. Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet J Rare Dis. 2020; Jun 12;15(1):149. DOI:10.1186/s13023-020-01413-9.
   PubMed Web of Science ®Google Scholar
• Horton DK, Graham S, Punjani R, et al. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1–2):126–133. DOI:10.1080/21678421.2017.1406953.
   PubMed Web of Science ®Google Scholar
• Meyer R, Spittel S, Steinfurth L, et al. Patient-reported outcome of physical therapy in amyotrophic lateral sclerosis: observational online study. JMIR Rehabil Assist Technol. 2018; Nov 12;5(2):e10099. DOI:10.2196/10099.
   PubMedGoogle Scholar
• Sznajder J, Barć K, Kuźma-Kozakiewicz M. Physical activity in patients with amyotrophic lateral sclerosis: prevalence, patients’ perspectives and relation to the motor performance. NeuroRehabilitation. 50(4): Online ahead of print:433–443. 2022; Feb 15. DOI:10.3233/NRE-210312
   PubMed Web of Science ®Google Scholar
• Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018; Aug 7;11:156–164. DOI:10.1016/j.conctc.2018.08.001
   PubMed Web of Science ®Google Scholar
• Shefner JM, Cudkowicz ME, Hardiman O, et al. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1–11.
   PubMedGoogle Scholar
• Collins KA, Huffman KM, Wolever RQ, et al. Determinants of dropout from and variation in adherence to an exercise intervention: the STRRIDE randomized trials Transl J Am Coll Sports Med. 2022 Winter;7:1e000190. DOI:10.1249/TJX.0000000000000190
   PubMedGoogle Scholar
• Medina-Perez C, de Souza-Teixeira F, Fernandez-Gonzalo R, et al. Effects of high-speed power training on muscle strength and power in patients with multiple sclerosis. J Rehabil Res Dev. 2016;53(3):359–368.
   PubMedGoogle Scholar